Grey Wolf Animal Health Corp (WOLF) Stock Statistics & Valuation Metrics
Total Valuation
Grey Wolf Animal Health Corp has a market cap or net worth of CAD 57.16M. The enterprise value is CAD 75.94M.
- Market Cap
- CAD 57.16M
- Enterprise Value
- CAD 75.94M
Share Statistics
Grey Wolf Animal Health Corp has 34,640,293 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 34,640,293
- Owned by Insiders
- 0.06%
- Owned by Institutions
- ―
Financial Efficiency
Grey Wolf Animal Health Corp’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Grey Wolf Animal Health Corp had revenue of ― and earned -404.58K in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- ―
- Operating Income
- -415.17K
- Pretax Income
- ―
- Net Income
- -404.58K
- EBITDA
- -404.58K
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- -0.10
- 52-Week Price Change
- 23.13%
- 50-Day Moving Average
- 1.69
- 200-Day Moving Average
- 1.59
- Relative Strength Index (RSI)
- 46.77
- Average Volume (3m)
- 17.68K
Important Dates
Grey Wolf Animal Health Corp upcoming earnings date is Nov 19, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 25, 2026
- Next Earnings Date
- Nov 19, 2026
- Ex-Dividend Date
- ―
Balance Sheet
Grey Wolf Animal Health Corp has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- CAD 0.00
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for Grey Wolf Animal Health Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 21.33%
- EPS Growth Forecast
- 83.13%